Table 2 Characteristics of Patients with AMI treated in VHA
Mean age, mean ± SD, y | 76.9 ± 6.9 |
Age, % | |
65-69 y | 16.9 |
70-79 y | 46.1 |
80-89 y | 34.1 |
>90 y | 2.9 |
Ethnicity, % | |
Hispanic | 6.9 |
African American | 9.4 |
White | 57.8 |
Other | 0.6 |
Unknown | 25.3 |
Distance from home to hospital in miles, mean ± SD | 39 ± 117 |
Geographic region of medical center, % | |
New England | 3.2 |
Mid-Atlantic | 10.0 |
Great Lakes | 10.6 |
North Plants | 8.7 |
South Atlantic (including Puerto Rico) | 28.3 |
Mississippi | 7.7 |
South Plains | 11.5 |
Great Basin | 9.5 |
Pacific | 10.6 |
Medical history, % | |
Myocardial infarction | 26.5 |
Lipid disorder | 64.3 |
Coronary angioplasty/PCI w/in 6 mos | 3.5 |
Coronary artery bypass surgery | 23.8 |
Heart failure | 37.7 |
Diabetes mellitus | 63.4 |
Renal disease | 18.6 |
Cerebrovascular disease | 9.6 |
Chronic obstructive pulmonary disease | 21.7 |
Dementia | 16.3 |
Cancer | 11.5 |
Current smoking | 13.5 |
Medications at the time of admission for AMI, % | |
Aspirin | 49.8 |
Beta-blocker | 57.3 |
Angiotensin-converting enzyme inhibitor | 48.4 |
Lipid-lowering drug | 54.9 |
Insulin | 15.6 |